ASLNASLAN Pharmaceuticals Ltd

Nasdaq www.aslanpharma.com


$ 0.68 $ -0.41 (-36.95 %)    

Wednesday, 17-Jul-2024 15:58:20 EDT
QQQ $ 482.23 $ -14.57 (-2.94 %)
DIA $ 412.29 $ 2.27 (0.55 %)
SPY $ 557.05 $ -7.92 (-1.4 %)
TLT $ 94.21 $ 0.02 (0.02 %)
GLD $ 227.29 $ -1.06 (-0.46 %)
$ 0.6999
$ 0.50
$ 0.00 x 0
$ 0.00 x 0
$ 0.50 - $ 0.79
$ 0.48 - $ 25.44
2,791,288
na
10.68M
$ 1.66
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-aslan-pharmaceuticals-asln-shares-are-down-40

ASLAN Pharmaceuticals shares are trading lower by 40.6% during Wednesday's session. The company announced that its Singapor...

 aslan-pharmaceuticals-announces-receipt-of-nasdaq-delisting-determination-for-non-compliance-of-bid-price-and-stockholders-qquity-requirements

ASLAN Pharmaceuticals (("ASLAN" or the "Company", NASDAQ:ASLN), a clinical-stage, immunology-focused biopharmac...

 aslan-pharmaceuticals-announces-plan-to-implement-ads-ratio-change-from-1-ads-representing-25-shares-to-1-ads-representing-200-shares-1-for-8-ads-split-effective-date-for-the-ratio-change-july-3-2024

ASLAN Pharmaceuticals (("ASLAN" or the "Company", NASDAQ:ASLN), a clinical-stage, immunology-focused biopharmac...